Dr. Hassan Alli

Hassan Alli is an ophthalmologist and clinical researcher based in South Africa, with academic affiliations linked to major Johannesburg teaching hospitals. His work centres on uveitis, ocular tuberculosis, neuro-ophthalmology, and paediatric strabismus, with a strong focus on conditions prevalent in high TB and HIV settings. He is recognized for advancing evidence-based approaches to inflammatory and infectious eye disease in sub-Saharan Africa.

A significant portion of his research addresses tubercular uveitis, including prospective cohort studies and systematic reviews that clarify prevalence, diagnostic challenges, and treatment outcomes in high-burden regions. These contributions highlight the complexity of diagnosis without a gold standard and inform optimal duration of therapy. His work on optic neuritis further expands regional data on neuro-ophthalmic disease presentation and prognosis.

In paediatric ophthalmology, Alli has examined botulinum neurotoxin versus surgical management for infantile esotropia, integrating clinical efficacy and cost analyses relevant to resource-limited systems. He has also contributed to collaborative studies on the impact of COVID-19 on ophthalmic surgery across Africa and on rare anatomical conditions such as nanophthalmos. His scholarship reflects methodological strength in cohort studies and meta-analyses with direct policy and clinical relevance.